We next investigated the impact of somatic ERCC2 mutations identified in bladder cancer cohorts (Figure 2B) on cell fitness in the TP53 KO (Figure 2D) and WT cell lines (Supplemental Figure 2D). Here, ERCC2 is linked to urinary bladder carcinoma.